Therefore, we focused on the role of PFKFB4 in the effects of LXX-8250 in melanoma, and confirmed the downregulation of PFKFB4 expression by LXX-8250 treatment (Figures 3C–F, Figure 6D). The gene discussed is PFKFB4; the disease is melanoma.